ARCHIVES

Revlimid Plus Steroid Effective In Clinical Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | November 30, 2007

Download PDF Visit The Full Archive

Related Articles

DCE Board Ok’s New RFA Programs worth $14 Million

June 29, 1990

New Concept For Prevention Units Goes to DCPC BSC

April 24, 1987

Cancer Nurses Urged To Take ‘Proactive Stance’ against Budget Cutting

October 16, 1987

Sept. Is AMA’s Month of Women In Medicine

September 10, 1993

ASCO 2012: Michael Link’s Presidential Address, and the 2012 Award Winners

June 8, 2012

Rogers Bill Would Authorize $937 Million For NCI In ‘78

March 4, 1977